41 Results for "

VISTA

" in MedChemExpress (MCE) Product Catalog:
Products (41)

41 Results for "VISTA" in MCE Product Catalog:

  • Targets Recommended:
  • Recombinant Proteins Recommended:
2
2 Cited Publications
Cat. No.: HY-101093
CAS No.: 1673534-76-3
Purity:  99.39%
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

CA-170 is an orally delivered dual inhibitor of VISTA and PD-L1. CA-170 exhibits potent rescue of proliferation and effector functions of T cells inhibited by PD-L1/L2 and VISTA with selectivity over other immune checkpoint proteins as well as a broad panel of receptors and enzymes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99040
CAS No.: 1969313-51-6
Synonyms: JNJ-61610588; CI-8993; VSTB112

Target:  

VISTA

Research Areas:  

Cancer

Onvatilimab (JNJ-61610588) is a human IgG1κ anti-VISTA (V-domain Ig Suppressor of T-cell Activation) monoclonal antibody. Onvatilimab can be used in colorectal cancer research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P991447

Target:  

VISTA

Research Areas:  

Cancer

Anti-VSIR/VISTA Antibody (SG7) is an antibody targeting VISTA, with a Kd of 0.14 nM for human VISTA and 1 nM for mouse VISTA. Anti-VSIR/VISTA Antibody (SG7) blocks the function of VISTA, prevents VISTA from binding to T cells, restores suppressed T cell activation, and blocks the interactions between VISTA and PSGL-1 as well as VSIG3. Anti-VSIR/VISTA Antibody (SG7) slows tumor growth, reduces PMN-MDSCs, and increases the numbers of CD4 + and CD8 + T cells in the tumor microenvironment. Anti-VSIR/VISTA Antibody (SG7) can be used in studies related to melanoma, colon cancer, and breast cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P72428
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VSIR; V-Set Immunoregulatory Receptor; C10orf54; SISP1; VISTA; B7-H5; PD-1H; Dies1; GI24; B7H5; V-Type Immunoglobulin Domain-Containing Suppressor Of T-Cell Activation; V-Set Domain-Containing Immunoregulatory Receptor; V-Domain Ig Suppressor Of T Cell Ac
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P990145

Target:  

VISTA

Research Areas:  

Inflammation/Immunology Cancer

Anti-Mouse VISTA Antibody (13F3) is an anti-mouse VISTA IgG monoclonal antibody. Anti-Mouse VISTA Antibody (13F3) can reverse the immunosuppressive effect of VISTA by blocking its binding to ligands such as VSIG3. Anti-Mouse VISTA Antibody (13F3) exacerbates pulmonary fibrosis (PF) by promoting Th17 cell differentiation. Anti-Mouse VISTA Antibody (13F3) can be used for research on cancer such as breast cancer and PF .
loading...
    loading...
Cat. No.: HY-13570C
CAS No.: 151-73-5
Purity:  99.84%
Synonyms: Betamethasone 21-phosphate disodium salt; VISTA-Methasone
Betamethasone disodium phosphate (Betamethasone 21-phosphate disodium salt; Vista-Methasone) is a corticosteroid. Betamethasone disodium phosphate is used in research related to inflammatory and immune diseases such as keloids .
loading...
    loading...
Cat. No.: HY-155971
CAS No.: 2614183-36-5
Purity:  99.44%
Target:  

Autophagy

Research Areas:  

Inflammation/Immunology Cancer

VISTA-IN-2 (Compound 1) is an inhibitor of V-domain Ig suppressor of T-cell activation (VISTA). VISTA-IN-2 induces VISTA degradation in cells through an autophagic mechanism. VISTA-IN-2 rescues VISTA-mediated immunosuppression, and enhances antitumor activity of immune cells. VISTA-IN-2 also activates the antitumor immunity and inhibits tumor growth in a CT26 mouse model .
loading...
    loading...
Cat. No.: HY-147311
CAS No.: 2593254-90-9
Purity:  99.53%
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology

NSC622608 is a V-domain Ig suppressor of T-cell activation (VISTA) ligand with an IC50 value of 4.8 μM .
loading...
    loading...
Cat. No.: HY-157937
CAS No.: 2994662-45-0
Purity:  99.83%
Target:  

IFNAR

Research Areas:  

Cancer

VISTA-IN-3 (Compound A4) is a potent VISTA small molecule inhibitor with a KD value of 0.49 μM. VISTA-IN-3 can induce the release of IFN-γ cytokines. VISTA-IN-3 synergistically enhances anti-cancer activity with PD-L1 antibody .
loading...
    loading...
Cat. No.: HY-W014159
CAS No.: 55289-35-5
1-Bromo-2-methyl-3-nitrobenzene is an organic synthesis intermediate. 1-Bromo-2-methyl-3-nitrobenzene participates in chemical reactions such as electrophilic substitution and coupling through the bromine atom and nitro group in the molecule, and acts as a synthetic precursor. 1-Bromo-2-methyl-3-nitrobenzene can construct complex molecular structures by relying on the leaving property of bromine and the electron-withdrawing property of nitro group, and can be used in the synthesis of benzimidazole VISTA inhibitors in medicinal chemistry .
loading...
    loading...
Cat. No.: HY-169853
CAS No.: 1189495-81-5
M351-0056 is an orally active VISTA agonist with a Kd value of 12.60 μM. M351-0056 inhibits the activation of the JAK2-STAT2 pathway, reduces the phosphorylation levels of JAK2 and STAT2, and regulates type I interferon (IFN-I) and non-canonical NF-κB pathways. M351-0056 decreases the levels of cytokines (IFN-γ, IL-17A, TNF-α, IL-2 and IL-1β). M351-0056 improves imiquimod (HY-B0180)-induced psoriasis-like skin inflammation, reduces autoantibody levels, kidney damage and immune cell expansion in mice susceptible to chronic graft-versus-host disease and lupus, and delays the progression of systemic lupus erythematosus. M351-0056 can be used in research related to psoriasis-like dermatitis and systemic lupus erythematosus .
loading...
    loading...
Cat. No.: HY-172396
Target:  

PD-1/PD-L1 VISTA

Research Areas:  

Cancer

PD-L1/VISTA-IN-2 (Compound S8) is an orally active bifunctional PD-L1/VISTA inhibitor with an IC50 of 1.4 μM for PD-L1 and a KD of 2.1 μM for VISTA. PD-L1/VISTA-IN-2 can activate the tumor immune microenvironment and exert anti-cancer effects .
loading...
    loading...
Cat. No.: HY-P11253
Target:  

VISTA

Research Areas:  

Inflammation/Immunology

DOTA-Bn-CA-170 is a molecular probe targeting the VISTA protein, with a Kd value of 0.124 nM. DOTA-Bn-CA-170 is formed by covalently linking the p-SCN-Bn-DOTA ligand with CA-170 (HY-101093). DOTA-Bn-CA-170 labeled with [ 68Ga]Ga successfully achieves specific and high-contrast PET imaging of VISTA expression in various tumor-bearing mouse models. DOTA-Bn-CA-170 can be used for the study of VISTA-targeted immunotherapy .
loading...
    loading...
Cat. No.: HY-159894
Target:  

Autophagy

Research Areas:  

Cancer

Autophagy-lysosome activator-1 (Compound F1) is a Autophagy-lysosome activator. Autophagy-lysosome activator-1 effectively induces PD-L1 or VISTA degradation in tumor cells .
loading...
    loading...
Cat. No.: HY-170793
CAS No.: 2978623-09-3
Target:  

PD-1/PD-L1 VISTA

Research Areas:  

Cancer

PD-L1/VISTA-IN-1 (Compound P17) is an orally active dual-target inhibitor of PD-L1 and VISTA. PD-L1/VISTA-IN-1 can block the PD-1/PD-L1 interaction (IC50: 0.1492 μM) and the VISTA pathway (KD: 0.2723 μM), thereby reactivating T cells. PD-L1/VISTA-IN-1 has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-13570CR
CAS No.: 151-73-5
Synonyms: Betamethasone 21-phosphate disodium salt (Standard); VISTA-Methasone (Standard)
Research Areas:  

Others

Betamethasone disodium phosphate (Standard) (Betamethasone 21-phosphate disodium salt (Standard); Vista-Methasone (Standard)) is the analytical standard of Betamethasone disodium phosphate. This product is intended for research and analytical applications. Betamethasone disodium phosphate (Betamethasone 21-phosphate disodium salt; Vista-Methasone) is a corticosteroid. Betamethasone disodium phosphate is used in research related to inflammatory and immune diseases such as keloids .
loading...
    loading...
Cat. No.: HY-147179
CAS No.: 2734878-18-1
Purity:  99.47%
Target:  

ADC Payloads

Research Areas:  

Inflammation/Immunology

INX-SM-56 is a cytotoxin that can be used for the synthesis of anti-VISTA antibody agent conjugate. VISTA: V-region Immunoglobulin-containing Suppressor of T cell Activation .
loading...
    loading...
Cat. No.: HY-P11252
Research Areas:  

Cancer

DOTA-CA-170 is a DOTA-modified VISTA targeting agent CA-170. DOTA-CA-170 can be radiolabeled. DOTA-CA-170 can be used in the research of visualizing and distinguishing VISTA expression .
loading...
    loading...
Cat. No.: HY-Q25865
CAS No.: 920157-23-9
Target:  

VISTA

Research Areas:  

Cancer

MG-V-53 is a potent small molecule V domain T-cell activating immunoglobulin suppressor (VISTA) inhibitor with IC50 value of 121 nM. MG-V-53 has antitumor activity .
loading...
    loading...
Cat. No.: HY-P991421

Target:  

VISTA

Research Areas:  

Cancer

W0180 is a human IgG1 monoclonal antibody (mAb) targeting VISTA/B7-H5. W0180 has the potential to activate T cells. W0180 can be used in solid tumors research .
loading...
    loading...